Due to its strong chemotactic activity, MCP-1 has the ability to recruit monocytes into inflamed blood vessel walls, which is one of the earliest events in atherosclerosis, and eventually advance the progression of plaque instability and vascular injury [8]. The gene discussed is CCL2; the disease is atherosclerosis.